Skip to main content

Table 1 Dose objectives for traditional dose optimization on HT and TD

From: Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations

Structure Parameter Objective
PTV Dmean(Gy) 30
  V90% (%) 99
  V95% (%) 95
  V107% (%) 1
Breast V4Gy (%) 50
  V10Gy (%) 33
Lung V5Gy (%) 50
  V10Gy (%) 33
Thyroid V18Gy (%) 50
  V25Gy (%) 33
Heart V7.7Gy (%) 50
  V15Gy (%) 33
Coronary Ostia V20Gy (%) 100